Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading

Jiang Chang, Lei Wei, Takayuki Otani, Keith A. Youker, Mark L. Entman, Robert J. Schwartz

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background - Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure. Methods and Results - We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of α-actin gene promoters by 50% to 60%, which suggests that truncated SRF functioned as a dominant-negative transcription factor. Conclusions-Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.

Original languageEnglish (US)
Pages (from-to)407-413
Number of pages7
JournalCirculation
Volume108
Issue number4
DOIs
StatePublished - Jul 29 2003
Externally publishedYes

Fingerprint

Serum Response Factor
Caspase 3
Transcription Factors
Heart Failure
Genes
Heart-Assist Devices
Site-Directed Mutagenesis
Actins

Keywords

  • Apoptosis
  • Heart failure
  • Heart-assist device
  • Serum response factor

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. / Chang, Jiang; Wei, Lei; Otani, Takayuki; Youker, Keith A.; Entman, Mark L.; Schwartz, Robert J.

In: Circulation, Vol. 108, No. 4, 29.07.2003, p. 407-413.

Research output: Contribution to journalArticle

Chang, Jiang ; Wei, Lei ; Otani, Takayuki ; Youker, Keith A. ; Entman, Mark L. ; Schwartz, Robert J. / Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. In: Circulation. 2003 ; Vol. 108, No. 4. pp. 407-413.
@article{a0ece21b5da64296a55221996caca3cb,
title = "Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading",
abstract = "Background - Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure. Methods and Results - We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of α-actin gene promoters by 50{\%} to 60{\%}, which suggests that truncated SRF functioned as a dominant-negative transcription factor. Conclusions-Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.",
keywords = "Apoptosis, Heart failure, Heart-assist device, Serum response factor",
author = "Jiang Chang and Lei Wei and Takayuki Otani and Youker, {Keith A.} and Entman, {Mark L.} and Schwartz, {Robert J.}",
year = "2003",
month = "7",
day = "29",
doi = "10.1161/01.CIR.0000084502.02147.83",
language = "English (US)",
volume = "108",
pages = "407--413",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading

AU - Chang, Jiang

AU - Wei, Lei

AU - Otani, Takayuki

AU - Youker, Keith A.

AU - Entman, Mark L.

AU - Schwartz, Robert J.

PY - 2003/7/29

Y1 - 2003/7/29

N2 - Background - Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure. Methods and Results - We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of α-actin gene promoters by 50% to 60%, which suggests that truncated SRF functioned as a dominant-negative transcription factor. Conclusions-Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.

AB - Background - Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure. Methods and Results - We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of α-actin gene promoters by 50% to 60%, which suggests that truncated SRF functioned as a dominant-negative transcription factor. Conclusions-Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.

KW - Apoptosis

KW - Heart failure

KW - Heart-assist device

KW - Serum response factor

UR - http://www.scopus.com/inward/record.url?scp=0042164600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042164600&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000084502.02147.83

DO - 10.1161/01.CIR.0000084502.02147.83

M3 - Article

C2 - 12874181

AN - SCOPUS:0042164600

VL - 108

SP - 407

EP - 413

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 4

ER -